The latest announcement is out from Oncology Institute, Inc. ( (TOI) ).
Maeve O’Meara plans to resign from The Oncology Institute’s Board of Directors by January 1, 2025, not due to any internal disputes. Gabriel Ling will step in as an independent director, ensuring a majority of independent directors in compliance with Nasdaq rules, maintaining stability and governance for investors.
For a thorough assessment of TOI stock, go to TipRanks’ Stock Analysis page.
